Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
25.00
Ask:
28.00
Spread: 3.00 (12.00%)
Market Cap: £12.62m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Covid-19 Update

25 Mar 2020 07:00

RNS Number : 5156H
Pennant International Group PLC
25 March 2020
 

 

FOR IMMEDIATE RELEASE 25 March 2020

PENNANT INTERNATIONAL GROUP PLC

 

Covid-19 Update

 

Pennant International Group plc ("Pennant", the "Group", or the "Company"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, issues the following Covid-19 update.

Current Risks

The Group continues to assess and manage the impact of Covid-19 on its business. Three key risks to trading and prospects have been identified so far.

The first is the challenge of holding review events with customers. Such review events are held, as physical meetings, through the lifecycle of an engineering programme and frequently have milestone payments attached (paid by the customer to Pennant upon successful completion of the review). If the review cannot be held due to Covid-19 restrictions, cash and revenue associated with completion of the milestone may be delayed.

The second risk is the inability to gain access to customer facilities to deliver services. Our 'integrated logistics support' consultancy services are typically delivered at a customer's site; if we cannot access the relevant site due to Covid-19 restrictions, the ability to deliver the services is severely hampered.

Lastly, there is the broader risk that governments and major OEMs which award contracts to Pennant are, in the shorter term at least, consumed by their own efforts to deal with Covid-19 and therefore expected contract awards are consequently delayed until the pandemic has abated.

Actions Taken

With the first two risks set out above, we are working closely with the applicable customers to establish solutions so that reviews and services can be held and provided via remote means. We are confident that workarounds will be possible (and in some cases, these are already being implemented) but the impact on the timing and amount of any affected revenues is not yet clear. The third, macro risk is less easy for Pennant to directly influence, but we remain in close contact with key stakeholders to ensure we are well-informed and remain well-placed for awards.

Simultaneously, we are prioritising the safety and well-being of our employees and other stakeholders and have implemented near-total homeworking already.

Financial Position

We are actively focused on cash and cost management across the business and retain undrawn facilities.

We welcome certain UK Government initiatives to support businesses in these exceptional times, and we have already utilised the UK Government's Coronavirus Job Retention Scheme to protect (and part-fund) the jobs of those employees who are currently unable to carry out their usual duties due to Covid-19 interruption.

We are also investigating other potential financial options, including the Coronavirus Business Interruption Loan Scheme, with a view to securing access to further funding should it be required.

Outlook

With the UK Government's unprecedented restrictions on travel, social and business contact, providing forward guidance is extremely difficult but the Board will be keeping the situation under very close review. The Company intends to announce preliminary results for the year ended 31 December 2019 on Monday 20 April 2020 and will provide a further update at that point.

The Board is confident that the Group's underlying strengths - our long-term customer relationships with governments and major OEMs, contracted order book, specialist services and our quality-assured reputation - will continue to provide a solid foundation for our long-term success.

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

 

+44 (0) 1452 714 914

David Clements, Commercial & Risk Director

 

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Chris Savidge

+44 (0) 117 945 3470

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFIFSRVLIEFII
Date   Source Headline
24th Oct 20228:31 amRNSDirectorate Change
21st Sep 20227:00 amRNS2022 Interim Results
9th Aug 20225:51 pmRNSIssue of Equity, Director/PDMR Dealings & TVR
9th Aug 202210:32 amRNSHoldings in Company
3rd Aug 20227:00 amRNSSale of Pennant Court
28th Jul 20227:00 amRNSTrading Update & Notice of Interim Results
30th Jun 20227:00 amRNSNotice of Capital Markets Day
22nd Jun 202210:27 amRNSResult of AGM
27th May 202210:56 amRNSNotice of AGM
25th May 20227:00 amRNS2021 Final Results
29th Apr 20227:00 amRNSNotice of Final Results
19th Apr 20221:42 pmRNSHolding in Company
6th Apr 20227:00 amRNSIssue of Equity, Director/PDMR Dealings & TVR
23rd Mar 20227:00 amRNSContracts & Order Book Update
21st Jan 202210:19 amRNSMajor Programme Update
20th Jan 20229:05 amRNSSecond Price Monitoring Extn
20th Jan 20229:00 amRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSTrading Update
16th Dec 202110:55 amRNSHolding in Company
3rd Dec 202111:20 amRNSMajor Programme Update
17th Nov 202112:04 pmRNSHolding in Company
11th Nov 20215:13 pmRNSDirectorate Change
1st Nov 20211:23 pmRNSHolding in Company
28th Oct 20212:26 pmRNSHolding in Company
12th Oct 20212:44 pmRNSGrant of Option
30th Sep 20215:02 pmRNSHolding in Company
28th Sep 20214:31 pmRNSHolding in Company
27th Sep 20215:02 pmRNSHolding(s) in Company
23rd Sep 20217:00 amRNSDirector/PDMR Share Purchases
22nd Sep 20217:00 amRNS2021 Interim Results
7th Sep 20212:44 pmRNSHolding in Company
31st Aug 20212:05 pmRNSSecond Price Monitoring Extn
31st Aug 20212:00 pmRNSPrice Monitoring Extension
31st Aug 20217:00 amRNSTrading Update & Notice of Interim Results
2nd Jun 20214:48 pmRNSResults of AGM & Appointment of new Chairman
27th May 20217:00 amRNSAGM Update
29th Apr 20213:31 pmRNSNotice of AGM
28th Apr 20212:05 pmRNSSecond Price Monitoring Extn
28th Apr 20212:00 pmRNSPrice Monitoring Extension
28th Apr 20217:00 amRNS2020 Final Results
19th Apr 20217:00 amRNSRescheduling of 2020 Final Results
1st Apr 20214:46 pmRNSIssue of Equity & Director Dealings
10th Mar 20217:00 amRNSNotice of Final Results
9th Mar 20217:00 amRNSHoldings in Company
9th Mar 20217:00 amRNSHoldings in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
5th Oct 202011:02 amRNSHolding(s) in Company
5th Oct 202011:01 amRNSHolding(s) in Company
5th Oct 202011:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.